Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism (The ARTIST Study)

NCT06946732 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06946732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06946732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism (The ARTIST Study)
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2025
Completion date
December 31, 2026
Enrollment
127 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism (pe)